These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34929236)

  • 1. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment.
    Wang YQ; Jiang YJ; Zou MS; Liu J; Zhao HQ; Wang YH
    Behav Brain Res; 2022 Feb; 420():113724. PubMed ID: 34929236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
    Laudon M; Frydman-Marom A
    Int J Mol Sci; 2014 Sep; 15(9):15924-50. PubMed ID: 25207602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP; McLin DE; Dressman MA; Neubauer DN
    Pharmacotherapy; 2016 Sep; 36(9):1028-41. PubMed ID: 27500861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of depression: role of sleep and the melatonergic system.
    Srinivasan V; Pandi-Perumal SR; Trakht I; Spence DW; Hardeland R; Poeggeler B; Cardinali DP
    Psychiatry Res; 2009 Feb; 165(3):201-14. PubMed ID: 19181389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin: pharmacological aspects and clinical trends.
    Rios ER; Venâncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
    Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders.
    Geoffroy PA; Etain B; Franchi JA; Bellivier F; Ritter P
    Curr Pharm Des; 2015; 21(23):3352-8. PubMed ID: 26088111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.
    Hardeland R; Poeggeler B
    Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):189-216. PubMed ID: 22640220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: Deciphering Synergic Effects on Anti-Depressant Mechanisms.
    Satyanarayanan SK; Shih YH; Chien YC; Huang SY; Gałecki P; Kasper S; Chang JP; Su KP
    Mol Neurobiol; 2018 Sep; 55(9):7271-7284. PubMed ID: 29397559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.
    Catena-Dell'Osso M; Marazziti D; Rotella F; Bellantuono C
    Curr Med Chem; 2012; 19(3):428-37. PubMed ID: 22335516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine: An Astounding Sui-generis Antidepressant?
    Naveed M; Li LD; Sheng G; Du ZW; Zhou YP; Nan S; Zhu MY; Zhang J; Zhou QG
    Curr Mol Pharmacol; 2022; 15(7):943-961. PubMed ID: 34886787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of melatonin in the mouse chronic mild stress model.
    Detanico BC; Piato AL; Freitas JJ; Lhullier FL; Hidalgo MP; Caumo W; Elisabetsky E
    Eur J Pharmacol; 2009 Apr; 607(1-3):121-5. PubMed ID: 19249298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Melatonin Receptor Agonists and Parkinson's Disease.
    Noguchi Y; Masuda R; Aizawa H; Yoshimura T
    J Pineal Res; 2024 Aug; 76(5):e13002. PubMed ID: 39119925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S; Nishimon M; Nishino S
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin and its agonists: an update.
    Arendt J; Rajaratnam SM
    Br J Psychiatry; 2008 Oct; 193(4):267-9. PubMed ID: 18827285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin agonists and insomnia.
    Ferguson SA; Rajaratnam SM; Dawson D
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Steinhilber D
    Pharm Unserer Zeit; 2007; 36(3):213-7. PubMed ID: 17555058
    [No Abstract]   [Full Text] [Related]  

  • 18. Night shift hormone: How does melatonin affect depression?
    Kholghi G; Eskandari M; Shokouhi Qare Saadlou MS; Zarrindast MR; Vaseghi S
    Physiol Behav; 2022 Aug; 252():113835. PubMed ID: 35504318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS; Eastman CI
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.